[go: up one dir, main page]

BRPI0518399A2 - produÇço de beta-lactama - Google Patents

produÇço de beta-lactama

Info

Publication number
BRPI0518399A2
BRPI0518399A2 BRPI0518399-5A BRPI0518399A BRPI0518399A2 BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2 BR PI0518399 A BRPI0518399 A BR PI0518399A BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2
Authority
BR
Brazil
Prior art keywords
beta
lactam
production
lactam production
lactam compounds
Prior art date
Application number
BRPI0518399-5A
Other languages
English (en)
Inventor
Den Berg Marco Alexander Van
Roelof Ary Lans Bovenberg
Hendrik Jan Noorman
Bastiaan Romein
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0518399A2 publication Critical patent/BRPI0518399A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PRODUÇAO DE BETA-LACTAMA. A invenção atual descreve a transformação de um microrganismo que não produza naturalmente um composto do beta-lactam com os polinucleotídeos envolvidos no biosynthesis de compostos do beta-lactam e no uso de tais microrganismos transformados na produção de compostos do beta-lactam ou na identificação dos genes ou dos fatores envolvidos na síntese de um composto do beta-lactam.
BRPI0518399-5A 2004-12-10 2005-12-08 produÇço de beta-lactama BRPI0518399A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106471 2004-12-10
PCT/EP2005/056619 WO2006061425A2 (en) 2004-12-10 2005-12-08 Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms

Publications (1)

Publication Number Publication Date
BRPI0518399A2 true BRPI0518399A2 (pt) 2008-11-18

Family

ID=34930032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518399-5A BRPI0518399A2 (pt) 2004-12-10 2005-12-08 produÇço de beta-lactama

Country Status (8)

Country Link
US (1) US20080131925A1 (pt)
EP (1) EP1819813A2 (pt)
KR (1) KR20070085955A (pt)
CN (1) CN101098963A (pt)
BR (1) BRPI0518399A2 (pt)
MX (1) MX2007006780A (pt)
SG (1) SG158108A1 (pt)
WO (1) WO2006061425A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2084270B1 (en) * 2006-10-05 2013-11-20 DSM Sinochem Pharmaceuticals Netherlands B.V. Production of beta-lactam antibiotics
EP2080801A1 (en) * 2008-01-21 2009-07-22 Technical University of Denmark Production of non-ribosomal peptides in Saccharomyces
EP2123772A1 (en) * 2008-04-29 2009-11-25 DSM IP Assets B.V. Beta-lactam antibiotic producing strains
EP2376619A4 (en) 2008-12-15 2012-07-04 Greenlight Biosciences Inc METHOD OF FLOW CONTROL IN METABOLISM PATHS
US20110008867A1 (en) * 2008-12-22 2011-01-13 Greenlight Biosciences Compositions and methods for the production of a compound
EP2566953B1 (en) 2010-05-07 2019-01-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through enzyme relocation
KR101988063B1 (ko) 2010-08-31 2019-09-30 그린라이트 바이오사이언시스, 아이엔씨. 프로테아제 조작을 통한 대사 경로에서 유동의 제어 방법
CN104093848A (zh) 2011-09-09 2014-10-08 绿光生物科学公司 碳青霉烯(carbapenem)的无细胞制备
CN105658807A (zh) 2013-08-05 2016-06-08 绿光生物科技股份有限公司 具有蛋白酶切割位点的工程化蛋白
MY193444A (en) 2015-03-30 2022-10-13 Greenlight Biosciences Inc Cell-free production of ribonucleic acid
EP4293104A3 (en) 2016-04-06 2024-04-24 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
WO2018129275A1 (en) 2017-01-06 2018-07-12 Greenlight Biosciences, Inc. Cell-free production of sugars
WO2019075167A1 (en) 2017-10-11 2019-04-18 Greenlight Biosciences, Inc. METHODS AND COMPOSITIONS FOR THE PRODUCTION OF NUCLEOSIDE TRIPHOSPHATE AND RIBONUCLEIC ACID

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85535A (en) * 1987-03-04 1994-02-27 Lilly Co Eli Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase and deacetylcephalosporin c synthetase
US6258555B1 (en) * 1987-12-09 2001-07-10 Beecham Group P.L.C. DNA encoding ACV synthetase
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
US5882879A (en) * 1990-02-28 1999-03-16 Gist-Brocades, N.V. Method for influencing β-lactam antibiotic production and for isolation of large quantities of ACV synthetase

Also Published As

Publication number Publication date
WO2006061425A3 (en) 2006-08-03
US20080131925A1 (en) 2008-06-05
MX2007006780A (es) 2007-08-06
EP1819813A2 (en) 2007-08-22
CN101098963A (zh) 2008-01-02
WO2006061425A2 (en) 2006-06-15
SG158108A1 (en) 2010-01-29
KR20070085955A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
BRPI0518399A2 (pt) produÇço de beta-lactama
BRPI0520369A2 (pt) catalisador orgánico com compatibilidade intensificada de enzima
IL188803A0 (en) Low ph aerated products
NO20074179L (no) Prodrugs av 2,4-pyrimidindiaminforbindelser og deres anvendelse
BR0309556A (pt) Inibidores de metaloproteinase pirimidina-2,4,6-triona
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
BRPI0512060A (pt) compostos orgánicos
BRPI0606379A2 (pt) triazolftalazinas
ECSP014105A (es) COMPUESTOS DE PIRROLO [2,3-d] PIRIMIDINA
GT200200043A (es) Nuevos compuestos antiinflamatorios de bencimidazol
ATE479687T1 (de) Kinaseinhibitoren
BRPI0412894A (pt) tienopiridina e furopiridina inibidores de quinases
ECSP088824A (es) Prolinamidas sustituidas, su preparación y su uso como medicamentos
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
BRPI0418450A (pt) uso de resinas endurecìveis por radiação a base de resinas de cetona e/ou uréia-aldeìdo
ATE519849T1 (de) Herstellung von pravastatin
BRPI0507894A (pt) pirazolopirimidinas
BRPI0416479A (pt) derivado quinazolina, composição farmacêutica, e, processo para a preparação de um derivado de quinazolina
MY133969A (en) Indoloquinazolinones
GT200300231A (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BR0211903A (pt) Isoxazolopiridinonas
BR0312944A (pt) Oligonucleotìdeos para detecção de microorganismos
WO2008056360A9 (en) COMPOSITION BASED ON CHICK PEAS
BR0312770A (pt) Detecção de microorganismos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.